Works matching AU Mahboudi, Fereidoun


Results: 73
    1
    2
    3
    4
    5
    6
    7
    8

    Development of polyclonal heavy chain antibodies targeting programmed death ligand-1.

    Published in:
    Veterinary Research Forum, 2023, v. 14, n. 6, p. 323, doi. 10.30466/vrf.2022.553274.3461
    By:
    • Oghalaie, Akbar;
    • Shoari, Alireza;
    • Kazemi-Lomedasht, Fatemeh;
    • Rahimi-Jamnani, Fatemeh;
    • Mahboudi, Fereidoun;
    • Ghaderi, Hajarossadat;
    • Hosseininejad-Chafi, Mohammad;
    • Moazzami, Reza;
    • Ardalan, Arghavan Ashja;
    • Piri-Gavgani, Somayeh;
    • Shahbazzadeh, Delavar;
    • Behdani, Mahdi
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Improvement of Certolizumab Fab′ properties by PASylation technology.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74549-0
    By:
    • Mazaheri, Somayeh;
    • Talebkhan, Yeganeh;
    • Mahboudi, Fereidoun;
    • Nematollahi, Leila;
    • Cohan, Reza Ahangari;
    • Mirabzadeh Ardakani, Esmat;
    • Bayat, Elham;
    • Sabzalinejad, Masoumeh;
    • Sardari, Soroush;
    • Torkashvand, Fatemeh
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Novel trastuzumab‐DM1 conjugate: Synthesis and bio‐evaluation.

    Published in:
    Journal of Cellular Physiology, 2019, v. 234, n. 10, p. 18206, doi. 10.1002/jcp.28453
    By:
    • Abedi, Mehri;
    • Cohan, Reza Ahangari;
    • Mahboudi, Fereidoun;
    • Faramarzi, Mohammad Ali;
    • Fazel, Ramin;
    • Damavandi, Narges;
    • Ardestani, Mehdi Shafiee;
    • Davami, Fatemeh
    Publication type:
    Article
    49
    50